Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality

Coronavirus disease (COVID-19) reached pandemic proportions at the beginning of 2020 and continues to be a worldwide concern. End organ damage and acute respiratory distress syndrome are the leading causes of death in severely or critically ill patients. The elevated cytokine levels in severe patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Moradian, Negar, Gouravani, Mahdi, Salehi, Mohammad Amin, Heidari, Arash, Shafeghat, Melika, Hamblin, Michael R., Rezaei, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Libbey Eurotext 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792554/
https://www.ncbi.nlm.nih.gov/pubmed/33361013
http://dx.doi.org/10.1684/ecn.2020.0451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792554/
https://www.ncbi.nlm.nih.gov/pubmed/33361013
http://dx.doi.org/10.1684/ecn.2020.0451

Ejemplares similares